References
- Archer, J. (2003). Cardiac biomarkers: a review. Compar Clin Pathol 12:121–128.
- Bethell, D.B., Day, N.P.J., Dung, N.M., McMullin, C., Loan, H.T., Tam, D.T.H., et al. (1996) Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug- resistant thyphoid fever. Antimicrob Agents Chemother 40:2167–2172.
- Committee, on Infectious Diseases. (2006). The use of systemic fluoroquinolones. Pediatrics 118:1287–1292.
- Cortas, N.K., Wakid, N.W. (1990). Determination of organic nitrate in serum and urine by a kinetic cadmium reduction method. Clin Chem 36:1440–1443.
- Falagas, M.E., Rafailidis, P.I., Rosmarakis, E.S. (2007). Arrhythmias associated with fluoroquinolone therapy. Int J Antimicrob Agents 29:374–379.
- Gendrel, D., Chalumeau, M., Moulin, F., Raymond, J. (2003). Fluoroquinolones in paediatrics: a risk for the patient or the community? Lancet Infect Dis 3:537–546.
- Kashida, Y., Kato, M. (1997a). Toxic effects of quinolone antibacterial agents on the musculoskeletal system in juvenile rats. Toxicol Pathol 25:635–643.
- Kashida, Y., Kato, M. (1997b). Possible involvement of nitric oxide in the quinolone-induced tendon lesions in rats. Drugs Exp Clin Res 23(3–4):139–143.
- Ohkawa, H., Ohishi, N., Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358.
- Oliphant, C.M., Green, G.M. (2002). Quinolones: a comprehensive review. Am Fam Phys 65:455–464.
- Pispirigos, K., Chrysanthopoulos, K. (2001). Evaluation of cardiac subacute toxicity of ciprofloxacin in rats using serum biochemical parameters. Arzneimittel-Forschung 51:582–587.
- Pouzaud, F., Dutot, M., Martin, C., Debray, M., Warnet, J.M., Rat, P. (2006). Age-dependent effects on redox status, oxidative stress, mitochondrial activity, and toxicity induced by fluoroquinolones on primary cultures of rabbit tendon cells. Compar Biochem Physiol Part C 143:232–241.
- Schimmel, K.J.M., Richel, D.J., van den Brink, R.B.A., Guchelaar, R.J. (2004). Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev 30:181–191.
- Shah, A., Liu, M.C., Vaughan, D., Heller, A.H. (1999). Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500-mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effects of food on the absorption of ciprofloxacin oral suspension. J Antimicrob Chemother 43(Suppl A):49–54.
- Stahlmann, R. (2002). Clinical toxicological aspects of fluoroquinolones. Toxicol Lett 127:269–277.
- Young, P. (2003). Musculoskeletal disorders. In: Anne, L.e.e. (Ed.), Adverse Drug Reactions. 1 (pp 157–175 ). London: Pharmaceutical Press.